Quick Answer
Stemtech Corp reported Research And Development Expense of $13.8 thousand for the year ending 2023.
- This data is from Stemtech Corp's annual report (Form 10-K), filed with the SEC on July 10, 2024.
- XBRL data for this metric is available from 2020 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $0.00 | Q2 2022: $0.00 | Q3 2022: $0.00 | Q1 2023: $13.8 thousand | Q2 2023: $177.00 | Q3 2023: $0.00 | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 3 years of available data (2020 to 2023), Stemtech Corp's Research And Development Expense has grown by 1,740.0%.
- Historical annual values: Fiscal year 2023: $13.8 thousand | Fiscal year 2022: $0.00 | Fiscal year 2020: $750.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: